Nimustine hydrochloride
Indication
Relieve the subjective symptoms and signs of the following diseases: brain and neck cancer, brain tumors, lung cancer, digestive tract cancer (gastric cancer, colon/rectum cancer, esophageal cancer), malignant lymphoma and leukemia, etc.
Manufacturer
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
-
Founded in:
2005-02-22 -
Address:
No. 8, Taizhen Road, Taizhou Pharmaceutical Hi-tech Zone, Jiangsu Province -
Tax NO.:
91321200771524291U -
Registered Funds:
200 million yuan -
Website:
-
Email: